Adult VF/Pulseless VT (ACLS) — free guideline decision tool
This tool summarizes ACLS management of adult shockable rhythms (VF/pulseless VT): defibrillation energy, epinephrine timing, and antiarrhythmic dosing, per AHA 2020/2025.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Common questions
What does Adult VF/Pulseless VT (ACLS) do?
Use during resuscitation to anchor the sequence — immediate single defibrillation with high-quality CPR, epinephrine every 3–5 minutes, antiarrhythmics for refractory arrest, magnesium for torsades, and structured post-ROSC care.
How is the result calculated?
Branches: shock (biphasic 120–200 J + CPR + epinephrine 1 mg q3–5min) → refractory (amiodarone 300→150 mg or lidocaine 1–1.5 mg/kg, treat 5H5T) → torsades (magnesium 1–2 g) → ROSC (post-arrest care, TTM, reversible causes).
Is this a substitute for clinical judgement?
No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.
Run Adult VF/Pulseless VT (ACLS) now
This tool summarizes ACLS management of adult shockable rhythms (VF/pulseless VT): defibrillation energy, epinephrine timing, and antiarrhythmic dosing, per AHA 2020/2025.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.